Seres Therapeutics
MCRB
#8838
Rank
โ‚ฌ0.10 B
Marketcap
0,58ย โ‚ฌ
Share price
-6.92%
Change (1 day)
-16.67%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -โ‚ฌ0.13 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ89.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.13 Billion34.63%
2023 -โ‚ฌ89.15 Million-59.97%
2022 -โ‚ฌ0.23 Billion289.57%
2021 -โ‚ฌ57.17 Million-27.3%
2020 -โ‚ฌ78.64 Million23%
2019 -โ‚ฌ63.94 Million-30.11%
2018 -โ‚ฌ91.48 Million9.73%
2017 -โ‚ฌ83.38 Million-0.74%
2016 -โ‚ฌ84 Million70.96%
2015 -โ‚ฌ49.14 Million257.11%
2014 -โ‚ฌ13.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.23 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.24 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.39 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA